Crohn’s Disease
- Immune system of African Americans responds more strongly to bacterial infection, and it is partly genetic
- Crohn’s disease: Discovery of two subtypes could lead to better treatments
- Diarrhea-causing bacteria promote growth of Crohn’s-linked microbe in mice
- Certain alternative therapies may help patients with bowel disorders
- Additional interim data supporting long-term use of vedolizumab in patients with ulcerative colitis and Crohn’s disease published
- FDA approves Amjevita, a biosimilar to Humira
- New therapeutic target for Crohn’s disease
- Crohn’s disease: Potential treatment to prevent fibrosis uncovered
- Ginger nanoparticles show promise for inflammatory bowel disease
- Phase 3 results for Cx601 in treatment of complex perianal fistulas in patients with Crohn’s disease
- Autoimmune Diseases: All You Need to Know
- Mucus in Stool: What Does it Mean?
- The colon is defended from bacteria by a self-sacrificing sentinel cell
- Accidental daily dosing of weekly drug linked to deaths
- Anxiety and depression linked to recurrence of inflammatory bowel disease
- Ulcerative colitis patients may benefit from fecal transplantation
- New Phase 3 study findings show Stelara maintained clinical remission after one year of treatment in patients with moderate to severe Crohn’s disease
- Gut flora may lead to better diagnosis tool for liver disease and open new avenues for treatment
- Study advances understanding of colon cancer and colitis
- Immunization with bacteria promotes stress resilience, coping behaviors in mice
- When beneficial bacteria knock but no one is home
- Targeted antibiotic is easier on the gut microbiome
- Research collaboration IDs serum biomarkers that predict preclinical IBD development and complications
- ‘Specialty medical home’ seeks to provide patient-centered care for patients with inflammatory bowel diseases
- Findings light the way for new treatments in colitis, colon cancer
Editorial Board
0